A money manager at Carl Icahn’s investment firm is suing Bausch + Lomb Corp. and his billionaire employer, alleging he was ...

The great German choreographer's landmark work, which was first presented in 1978 in Wuppertal, is revived on the main stage ...

Bausch Health Companies recently completed fixed-income exchange offers, issuing US$1.60 billion of new 10.00% Senior Secured Notes due 2032 to refinance existing senior secured notes under Regulation ...

Bausch + Lomb's stock remains a "Hold" despite the latest financial results. Here's what investors need to keep in mind.

Shares of Bausch Health Company (NYSE: BHC) were jumping 4.4% at 10:54 a.m. ET on Wednesday after rising as much as 11.8% earlier in the day. The gain came after the company announced results so far ...

What Happened? Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 2.2% in the morning session after Citigroup upgraded its rating on the company's shares to Buy from Neutral and raised its ...

CVS Pharmacy is suing one of its largest suppliers in federal court, accusing Bausch Health and generic giant Teva of keeping ...

The beauty devices market offers growth opportunities through the demand for multifunctional, at-home tech, regional adoption ...

Bausch Health has a solid business model with steady revenue generation and strong operating income margins - but debt & litigation are crippling the business. The company's heavy debt of >$20bn, and ...

Bausch + Lomb, a company that started as a small optical goods shop in upstate New York and grew to become a global ophthalmic products business, is returning to the public markets. The company has ...

On Saturday night, at the Brooklyn Academy of Music, New York saw the last performance of the last work by Pina Bausch, “…como el musguito en la piedra, ay si, si, si …” (“like moss on a stone ”). The ...